Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer

International Journal of Cancer

Volumn 121, Issue 7, 2007, Pages 1543-1549

  Forgue Lafitte, Marie Elisabeth ^a   Fabiani, Bettina ^b   Levy, Pierre P ^c   Maurin, Nicole ^d   Flejou, Jean François ^b   Bara, Jacques ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL TENON   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Colonic neoplasms; Diverticulitis; Humans; MUC5AC; Ulcerative colitis

Indexed keywords

MUC5AC ANTIBODY; MUCIN 5AC; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY LABELING; ARTICLE; COLON ADENOCARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; DESCENDING COLON; DIVERTICULITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DIVERTICULITIS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; INTESTINAL MUCOSA; MIDDLE AGED; MUCINS; PRECANCEROUS CONDITIONS;

EID: 34548224209     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22865     Document Type: Article

References (48)

1. Filipe MI, Branfoot AC. Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 1974;34:282-90.
2. Bara J, Malarewicz A, Loisillier F, Burtin P. Antigens common to human ovarian mucinous cyst fluid and gastric mucosa. Br J Cancer 1977;36:49-56.
3. Bara J, Loisillier F, Burtin P. Antigens of gastric and intestinal mucous cells in human colonic tumours. Br J Cancer 1980;41:209-21.
4. Decaens C, Bara J, Rosa B, Daher N, Burtin P. Early oncofetal antigenic modifications during rat colonic carcinogenesis. Cancer Res 1983;43:355-62.
5. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C. Monoclonal antibodies against oncofetal mucin M1 antigens associated with pre-cancerous colonic mucosae. Cancer Res 1986;46:3983-9.
6. Bara J, Gautier R, Mouradian P, Decaens C, Daher N. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer 1991;47:304-10.
7. Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, Godeau F. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 1998;75:767-73.
8. Nollet S, Forgue-Lafitte ME, Kirkham P, Bara J. Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: expression in normal GI tract and colon tumors. Int J Cancer 2002;99:336-43.
9. Nollet S, Escande F, Buisine MP, Forgue-Lafitte ME, Kirkham P, Okada Y, Bara J. Mapping of SOMU1 and M1 epitopes on the apomucin encoded by the 5′ end of the MUC5AC gene. Hybrid Hybridomics 2004;23:93-9.
10. Bara J, Gautier R, Le Pendu J, Oriol R. Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Leb) antigens. Biochem J 1988;254:185-93.
11. Hammel PR, Forgue-Lafitte ME, Levy P, Voitot H, Vilgrain V, Flejou JF, Molas G, Gespach C, Ruszniewski P, Bernades P, Bara J. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas. Int J Cancer 1997;74:286-90.
12. Bara J, Languille O, Gendron MC, Daher N, Martin E, Burtin P. Immunohistological study of precancerous mucus modification in human distal colonic polyps. Cancer Res 1983;43:3885-91.
13. Bara J, Andre J, Gautier R, Burtin P. Abnormal pattern of mucus-associated M1 antigens in histologically normal mucosa adjacent to colonic adenocarcinomas. Cancer Res 1984;44:4040-5.
14. Buisine MP, Janin A, Maunoury V, Audie JP, Delescaut MP, Copin MC, Colombel JF, Degand P, Aubert JP, Porchet N. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 1996;110:84-91.
15. Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, Ho SB. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999;80:210-18.
16. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, Leggett BA, Jass JR. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. JHistochem Cytochem 1999;47:1039-48.
17. Myerscough N, Sylvester PA, Warren BF, Biddolph S, Durdey P, Thomas MG, Carlstedt I, Corfield AP. Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide. Glycoconj J 2001;18:907-14.
18. Bara J, Forgue-Lafitte ME, Maurin N, Flejou JF, Zimber A. Abnormal expression of gastric mucin in human and rat aberrant crypt foci during colon carcinogenesis. Tumour Biol 2003;24:109-15.
19. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 1994;107:1352-63.
20. Maurin N, Forgue-Lafitte M-E, Levy P., Zimber A, Bara J. The progression of tumors arising from large ACF is associated with the Muc5AC expression during rat colon MNNG carcinogenesis. Int J Cancer 2007;120:477-83.
21. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51.
22. Hovenberg HW, Davies JR, Herrmann A, Linden CJ, Carlstedt I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996;13:839-47.
23. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339:1277-84.
24. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
25. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
26. Kim DH, Kim JW, Cho JH, Baek SH, Kakar S, Kim GE, Sleisenger MH, Kim YS. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Int J Oncol 2005;27:957-64.
27. Dolara P, Caderni G, Lancioni L, Giannini A, Anastasi A, Fazi M, Castiglione G. Aberrant crypt foci in human colon carcinogenesis. Cancer Detect Prev 1997;21:135-40.
28. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-7.
29. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1991;1:57-60.
30. Nascimbeni R, Villanacci V, Mariani PP, Di Betta E, Ghirardi M, Donato F, Salerni B. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol 1999;23:1256-63.
31. Bara J, Nardelli J, Gadenne C, Prade M, Burtin P. Differences in the expression of mucus-associated antigens between proximal and distal human colon adenocarcinomas. Br J Cancer 1984;49:495-501.
32. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
33. Itzkowitz SH. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2006;35: 553-71.
34. Fujimitsu Y, Nakanishi H, Inada K, Yamachika T, Ichinose M, Fukami H, Tatematsu M. Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn J Cancer Res 1996;87:1199-203.
35. Van Seuningen I, Pigny P, Perrais M, Porchet N, Aubert JP. Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? Front Biosci 2001;6:D1216-34.
36. Chang SK, Dohrman AF, Basbaum CB, Ho SB, Tsuda T, Toribara NW, Gum JR, Kim YS. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 1994;107:28-36.
37. Enss ML, Cornberg M, Wagner S, Gebert A, Henrichs M, Eisenblatter R, Beil W, Kownatzki R, Hedrich HJ. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 2000;49:162-9.
38. Smirnova MG, Kiselev SL, Birchall JP, Pearson JP. Up-regulation of mucin secretion in HT29-MTX cells by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-6. Eur Cytokine Netw 2001;12:119-25.
39. Lievin-Le Moal V, Huet G, Aubert JP, Bara J, Forgue-Lafitte ME, Servin AL, Coconnier MH. Activation of mucin exocytosis and upregulation of MUC genes in polarized human intestinal mucin-secreting cells by the thiol-activated exotoxin listeriolysin O. Cell Microbiol 2002;4:515-29.
40. Sylvester PA, Walsh M, Myerscough N, Warren BF, Corfield AP, Thomas MG, Durdey P. Mucin gene expression in the ileoanal reservoir is altered and may be relevant to the risk of inflammation and dysplasia. Gut 2002;51:386-91.
41. Shaoul R, Okada Y, Cutz E, Marcon MA. Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 2004;38:488-93.
42. Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defence barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem 2006;54:1335-48.
43. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001;49:544-51.
44. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
45. Rubin DT, Kavitt RT. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am 2006;35:581-604.
46. Stefansson T, Ekbom A, Sparen P, Pahlman L. Increased risk of left sided colon cancer in patients with diverticular disease. Gut 1993;34: 499-502.
47. Stefansson T, Ekbom A, Sparen P, Pahlman L. Association between sigmoid diverticulitis and left-sided colon cancer: a nested, population-based, case control study. Scand J Gastroenterol 2004;39:743-7.
48. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 2005;100:1283-9.